DSIP (5 mg Vial) Dosage Protocol
- Table of Contents
- DSIP Dosage Chart
- Dosing & Reconstitution Guide
- Standard / Gradual Approach (3 mL = ~1.67 mg/mL)
- Advanced / Extended Approach
- Reconstitution Steps
- Supplies Needed
- Protocol Overview
- Dosing Protocol
- Storage Instructions
- Important Notes
- How This Works
- Potential Benefits & Side Effects
- Lifestyle Factors
- Injection Technique
- Important Note
- References
DSIP Dosage Chart
DSIP (Delta Sleep-Inducing Peptide) is dosed at 100 mcg–300 mcg daily via subcutaneous injection in educational protocols, usually before bedtime. A 5 mg vial reconstituted with bacteriostatic water yields about 1.67 mg/mL. This information is for research and educational use only.
- Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
- Typical daily range: 100–300 mcg once daily (gradual titration); advanced up to 500 mcg.
- Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain tissue and studied for its effects on sleep architecture and stress modulation[1][2]. Research indicates DSIP may promote delta-wave (slow-wave) sleep, modulate cortisol and ACTH levels, and exhibit stress-protective properties[3][4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read DSIP Peptide: Benefits, Uses, Side Effects, Dosage, and Research.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (3 mL = ~1.67 mg/mL)
Week
Daily Dose (mcg)
Units (per injection) (mL)
Week 1
100 mcg
6 units (0.06 mL)
Week 2
150 mcg
9 units (0.09 mL)
Week 3
200 mcg
12 units (0.12 mL)
Weeks 4–8
250–300 mcg
15–18 units (0.15–0.18 mL)
Advanced / Extended Approach
Week
Daily Dose (mcg)
Units (per injection) (mL)
Week 5
350–400 mcg
21–24 units (0.21–0.24 mL)
Weeks 6–8+
400–500 mcg
24–30 units (0.24–0.30 mL)
Note: Advanced dosing (beyond 300 mcg) is based on anecdotal experience; formal human studies have primarily used doses up to ~300 mcg daily[7]. Use the minimum effective dose and increase only if needed.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–12 week daily protocol with gradual titration.
- Peptide Vials (DSIP, 5 mg each):
- 8 weeks at ~200 mcg/day avg ≈ 2–3 vials
- 12 weeks at ~200 mcg/day avg ≈ 3–4 vials
- 12 weeks at ~300 mcg/day avg ≈ 5–6 vials
- Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- 3 vials: 9 mL → 1 × 10 mL bottle
- 5 vials: 15 mL → 2 × 10 mL bottles
- 6 vials: 18 mL → 2 × 10 mL bottles
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
Protocol Overview
Concise summary of the once-daily regimen.
- Goal: Support healthy sleep architecture and stress modulation over time[3][4].
- Schedule: Daily subcutaneous injections for 4–8 weeks (extend to 12 weeks if desired).
- Dose Range: 100–300 mcg daily with gradual titration; advanced up to 500 mcg.
- Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
Suggested daily titration approach.
- Start: 100 mcg daily; increase by ~50 mcg every 1–2 weeks as tolerated.
- Target: 250–300 mcg daily by Weeks 4–8.
- Frequency: Once per day (subcutaneous), typically before bedtime.
- Cycle Length: 4–8 weeks; optional extension to 12 weeks with periodic breaks.
- Timing: Evening administration preferred; rotate injection sites.
Storage Instructions
Proper storage preserves peptide quality.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document daily dose and site rotation to maintain consistency.
- Some research suggests DSIP effects may persist for multiple nights after dosing[2]; adjust frequency as needed.
How This Works
DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was first characterized in 1977 as a sleep-modulating factor isolated from rabbit brain[1]. Mechanistic studies suggest DSIP may influence sleep by modulating GABAergic transmission and interacting with opioid receptor systems[10]. Research indicates it can increase delta-wave (slow-wave) sleep duration without significantly altering REM sleep architecture[3]. Beyond sleep, DSIP has demonstrated stress-protective and adaptogenic properties in various models, potentially through modulation of the hypothalamic-pituitary-adrenal axis[4][11].
Potential Benefits & Side Effects
Observations from preclinical and clinical literature.
- May promote deeper, more restorative slow-wave sleep and improve subjective sleep quality[3][5].
- Research suggests potential stress-protective and anxiolytic-like effects[4][11].
- Some studies indicate DSIP does not induce pharmacological tolerance with continued use[2].
- Generally well tolerated in human studies; occasional mild injection-site reactions may occur with subcutaneous administration.
- Limited long-term safety data; periodic breaks are recommended as a precaution[6].
Lifestyle Factors
Complementary strategies for best outcomes.
- Maintain consistent sleep-wake schedules to reinforce circadian rhythms.
- Limit blue light exposure and stimulants (caffeine, nicotine) in the hours before bed.
- Create a cool, dark, quiet sleep environment.
- Incorporate regular physical activity, ideally earlier in the day.
- Manage stress through relaxation techniques (meditation, deep breathing).
Injection Technique
General subcutaneous guidance from clinical best-practice resources[12].
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[12][13].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[12].
- Rotate sites systematically (abdomen at least 2 inches from navel, thighs, upper arms) to avoid lipohypertrophy[13].
Important Note
This content is for educational purposes only and is not medical advice.
References
Schoenenberger GA, Monnier M (1977)
— Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci USA
European Journal of Anaesthesiology (2001)
— Delta sleep-inducing peptide: editorial review of mechanisms and clinical context
Schneider-Helmert D, Schoenenberger GA (1983)
— Effects of DSIP in man: multifunctional psychophysiological properties. Neuropsychobiology
Sudakov KV et al. (2004)
— Delta-sleep-inducing peptide sequelae: stress protective effect. Ann N Y Acad Sci
Schneider-Helmert D (1981)
— Acute and delayed effects of DSIP on human sleep behavior. Int J Clin Pharmacol Ther Toxicol
Graf MV, Kastin AJ (1984)
— Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev
Iyer KS et al. (1988)
— Sleep-inducing effect of low doses of DSIP in rats. Indian J Exp Biol
Manning MC et al. (2010)
— Stability of protein pharmaceuticals: an update. Pharm Res
Wang W (2000)
— Lyophilization and development of solid protein pharmaceuticals. Int J Pharm
Yehuda S, Carasso RL (1988)
— DSIP: brain mechanisms and function. Int J Neurosci
Khvatova EM et al. (2003)
— Delta sleep-inducing peptide: effect on oxidative stress in brain during different models. Biull Eksp Biol Med
CDC
— Vaccine administration: subcutaneous route (angle/site; no aspiration)
NCBI Bookshelf
— Medication Administration: Subcutaneous Injections (Open RN Nursing Skills)
Related research, protocols, and guides
Explore the available research context, protocol variants or comparisons, and practical guides. When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ. Related compounds and blends are comparisons only, not interchangeable.
Research overview
Other vial-size protocols
Evidence: Dosing and safety sources are linkedEditorial standards & corrections